Atlas Trials

Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma

Clinical trial NCT07766889 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07766889
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Squamous Cell CarcinomaHead and Neck CancerLocally Advanced Head and Neck CancerNeoadjuvant Therapy
Start date
2026-09-01
Primary completion
2027-06-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.